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Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) is recognized as a metabolic disorder largely seen in
urbanized populations. The purpose of this study was to assess prevalence and risk factors for NAFLD in a rural,
physically active, economically deprived population in Sri Lanka.
Methods: By visiting individual households in the community, 35-64 year old adults resident in two selected
estates in the Nuwara Eliya District of Sri Lanka, were invited to participate in the study. Blood pressure and
anthropometric measurements were made on all participants. Blood samples were obtained for the assay of fasting
glucose, serum lipids, serum insulin and alanine aminotransferase. NAFLD was diagnosed on established ultrasound
criteria for fatty liver in the absence of hepatitis B and C markers and high alcohol consumption.
Results: Of those invited, 403 (65%) participated in the study. Almost all participants were either Indian or Sri
Lankan Tamils and 53% were females. Prevalence of NAFLD was 18% in this population. Twice as many males were
diagnosed as having NAFLD compared to females. Male sex, high BMI, high waist circumference, high diastolic
blood pressure and high plasma glucose levels were significant predictors of NAFLD.
Conclusion: Nearly one in five people in this predominantly Indian Tamil, rural, physically active, economically
deprived population had NAFLD. The condition was associated with constituent features of the metabolic
syndrome. These results support studies reporting ethnic variations in disease susceptibility and suggest that
genetic factors may also play a role in determining disease risk.
Background
Non-alcoholic fatty liver disease (NAFLD) is now recog-
nized as the most common chronic liver condition in
most regions worldwide. The majority of patients with
this condition generally have simple hepatic steatosis
with no or mild nonspecific inflammation. However,
more active forms of the condition that include steato-
hepatitis can have significant clinical consequences
related to the development of cirrhosis and its complica-
tions or co-morbid cardiovascular disease [1].
The prevalence of NAFLD has accelerated in the last
few decades, paralleling the substantial increase in rates
of overweight and obese people in the general popula-
tion [1]. NAFLD was conventionally recognized as a
metabolic disorder largely confined to residents of afflu-
ent industrialized Western countries [2]. The estimated
prevalence ranges between 2.8% and 46% in the general
population in these countries depending on the screen-
ing test used [2]. However, it is now clear that NAFLD
is no longer a disease confined to affluent Western
societies. Emergence of NAFLD as a significant public
health problem in Asian populations, especially in
regions with significant industrialization or urbanization,
has been reported in several recent studies [3,4]. A
recent population based study from Sri Lanka reported
a NAFLD prevalence of 32.6% in an urban predomi-
nantly sedentary population [5]; Sri Lanka is currently
experiencing a surge in non–communicable diseases as
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a result of the epidemiologic and demographic transi-
tions that have interacted with lifestyle changes. How-
ever, data on NAFLD prevalence in less urbanized,
socioeconomically underprivileged populations in Sri
Lanka, and in most Asian countries, is not available.
This study aims to determine the prevalence of NAFLD
and its risk factors in the estate population of Sri Lanka,
a physically active, low socio-economic population
group.
Methods
This study was part of a large community-based investi-
gation on non-communicable diseases: the Ragama
Health Study (RHS) [5]. The RHS is a collaborative
study between the International Medical Centre of
Japan (IMCJ) and the Faculty of Medicine, University of
Kelaniya, Sri Lanka. Ethical approval for the study was
obtained from the Ethical Review Committees of the
Faculty of Medicine, University of Kelaniya and the
IMCJ.
Data from the estate component of the study are pre-
sented here. All participants in this study were recruited
from Nuwara Eliya; located approximately 180 kms
from Colombo, the capital city. Nuwara Eliya District
has the largest estate population (54% of the district’s
population) in the country. The estate sector is defined
as plantations of 20 acres or more in extent on which
there are 10 or more resident labourers [6]. According
to the Household Income and Expenditure Survey -
2006/07 [7], both median household income and expen-
diture in the estate sector are below that of the national
figures. Percentage with education upto Grade 10 in the
estate sector is only 3% as compared to 15% nationally.
In the estates, only about 10% own a vehicle (at least a
bicycle) as compared to 56% nationally and over 80% of
the estate residents report walking as the main mode of
travel.
Study population
The study population consisted of 620 adults in 35-64
year age group resident in two selected estates in the
Nuwara Eliya District. The estates were selected on fea-
sibility for future follow up and availability of sufficient
infrastructure facilities to conduct a risk assessment
study.
Sampling and subject recruitment
All individuals in the 35-64 year age group residing in
the two estates were invited to participate in the study
during the period March-June 2008. The list of employ-
ees maintained by the estate management was used as
the sampling frame. A doctor accompanied by health
personnel from the estate medical center visited indivi-
dual households in the community and invited people
to participate. Participants were requested to present
after a 12 h fast with any available health records. Writ-
ten consent was given by all adults agreeing to partici-
pate in the study.
Measurements
Participants were subjected to an interview, ultrasono-
graphic examination of the liver, anthropometric and
blood pressure measurements and collection of blood
samples. They were interviewed by trained community
volunteers to obtain information on socio-demographic
variables and lifestyle habits. Details regarding the type,
and amount of alcohol consumed and duration of drink-
ing were also obtained. All past medical records of the
subjects were analyzed and recorded. Normal cut-off
values were based on the revised Adult Treatment Panel
III (ATP III) criteria for metabolic syndrome for Asians
[8]. A 10 ml sample of venous blood was obtained from
each subject. This was used to determine fasting glu-
cose, serum lipids, serum insulin and serum alanine
aminotransferase activity (ALT). All subjects underwent
ultrasonography of the liver with a 8-MHz probe
(Toshiba Ultrasound Diagnostic Systems SSA-51 OA,
Toshiba Medical Systems Corporation, Otawara-City,
Tochigi-prefecture, Japan) by three doctors trained in
liver ultrasonography. Fatty liver was diagnosed in the
presence of two of the three following criteria: increased
hepatic echogenicity compared to the spleen or the kid-
ney, blurring of liver vasculature and deep attenuation
of the ultrasonographic signal. All subjects who had an
abnormal liver on ultrasound were screened for hepatitis
B and C (hepatitis B surface antigen [HBsAg] [Fujirebio,
Tokyo, Japan] and anti-hepatitis C virus [Ortho Quick
Chaser, third generation, c22-3, c200, NS5]). NAFLD
was diagnosed in subjects who fulfilled ultrasonographic
criteria for fatty liver, and who did not report alcohol
consumption above the safe limit (< 14 units/week for
men, < 7 units/week for females) and who were negative
for hepatitis B and C markers.
Statistical analysis
Data were entered in Epi Info 2000 (Centres for Disease
Control and Prevention, Atlanta, GA, USA) and logical
and random checks were done. Statistical analysis was
done using SPSS version 16.0 (SPSS, Chicago, IL, USA).
Continuous and categorical data were described using
mean and standard deviations (SD) and percentages.
Multivariate analysis was done using binary logistic
regression. P < 0.05 was considered as significant.
Results
Of the eligible 620 individuals in the two tea plantations,
403 participated in the study (response rate of 65%).
Complete data were available in 401 participants (212
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females). Almost all (99.3%) were either Indian Tamil
(77.3%) or Sri Lankan Tamil (22%). About 74% were
Hindus and 23% were Christians. Over 13% of the
females had either a high waist circumference (WC) or
a high Body Mass Index (BMI). Compared to females, a
higher percentage of males (16%) had a high WC. Preva-
lence of NAFLD was 17.9% in this population. Mean age
of those with NAFLD was 50.5 years (SD 7.9). Twice as
many males were diagnosed as having NAFLD com-
pared to females. The risk profile of the study subjects
is given in Table 1. On bivariate analysis, male sex,
higher education or income level, low or moderate levels
of physical activity, BMI ≥ 25 kg/m2, WC ≥ 90 cm in
males or ≥ 80 cm in females, systolic blood pressure of
≥ 130 mmHg, diastolic blood pressure of ≥ 85 mmHg,
fasting plasma glucose of ≥ 5.6 mmol/L, insulin resis-
tance (homeostasis model assessment of insulin resis-
tance [HOMA-IR], > 1) and triglycerides ≥ 1.7 mmol/L
were significantly associated with NAFLD (Table 2). On
multivariate analysis, male sex, BMI, WC, diastolic
blood pressure and plasma glucose were significant pre-
dictors of NAFLD. Those obese, defined either by high
waist circumference or high body mass index, were
approximately 5 times more likely to have NAFLD com-
pared to non-obese individuals (Table 3).
Discussion
Our study found a NAFLD prevalence of nearly 18%
despite this Indian Tamil ethnic population being from
a rural estate area of Sri Lanka with wages earned
mainly through manual labour, and where limited access
to food, sanitation and transport still exists. Like in
other studies, NAFLD was associated with constituent
features of the metabolic syndrome. Although much
lower than the 33% prevalence found in a community
based study in a relatively sedentary, urban Sri Lankan
population [5], the figure is well within the range of
16% to 23% identified by other population based studies
that have used ultrasonagraphy for diagnosis of NAFLD
[9,10]. A prevalence of NAFLD similar to our study has
been reported from Hong Kong, Korea and Malaysia
[10]. However, unlike in our population, access to exces-
sive amounts of food and low activity levels were impor-
tant features in these studies. Thus, our study
strengthens the existing evidence for Asian Indians’
increased predisposition to visceral fat accumulation; a
feature that may be present from birth [11,12].
Although liver biopsy remains the gold standard to con-
firm diagnosis of NAFLD, this is impractical in epidemio-
logical studies. Non-invasiveness and low cost of
ultrasonography makes it the most acceptable technique
to diagnose fatty liver in field epidemiological studies.
High sensitivity for diagnosing fatty liver has been
reported using imaging techniques, including ultrasono-
graphy [13]. The ultrsonographic criteria we used to detect
fatty liver have an adequate threshold for detection of stea-
tosis when more than 33% of hepatocytes contain fat on
liver histology [14]. Exclusion of those with evidence of
hepatitis B and C infections and an alcohol intake above
the safe limits are also prerequisites to diagnose NAFLD
[15]. One limitation of our study was obtaining informa-
tion on alcohol consumption only by direct questioning of
Table 1 Risk profile of the study subjects
Variable Males (n = 189) N (%) Females (n = 212) N (%) Total (n = 401) N (%)
BMI ≥ 25 kg/m2 19 (10.1) 28 (13.2) 47 (11.7)
High waist circumference1 30 (15.9) 29 (13.7) 59 (14.7)
Regular alcohol consumption2 103 (54.5) 16 (7.5) 119 (29.7)
Weekly alcohol consumption above safe limit3 34 (17.9) 6 (2.8) 40 (9.9)
Low/moderate activity levels4 46 (24.3) 45 (21.2) 91 (22.6)
High fasting plasma glucose5 60 (31.7) 39 (18.4) 99 (24.7)
Insulin resistance6 50 (26.5) 35 (16.5) 85 (21.1)
High systolic blood pressure7 115 (60.8) 117 (55.2) 232 (57.9)
High diastolic blood pressure8 93 (49.2) 93 (43.9) 186 (46.4)
High serum triglycerides9 83 (43.9) 56 (26.4) 139 (34.7)
Low serum HDL10 63 (33.3) 128 (60.4) 191 (47.6)
High ALT11 3 (1.6) 1 (0.5) 4 (0.9)
Fatty liver12 50 (26.5) 27 (12.7) 77 (19.2)
Prevalence of NAFLD 45 (23.8) 27 (12.7) 72 (17.9)
1waist circumference > 90 cm for men, > 80 cm for female, 2consumption of alcohol atleast once a week, 3> 14 units/week for men, > 7 units/week for females,
4as classified by International Physical Activity Questionnaire [IPAQ], 5fasting plasma glucose (FPG) ≥ 5.6 mmol/L or previously diagnosed type 2 diabetes,
6homeostasis model assessment of insulin resistance [HOMA-IR] > 1, 7 systolic blood pressure ≥ 180 mmHg, 8diastolic blood pressure ≥ 85 mmHg, 9triglycerides
≥ 1.7 mmol/L, 10HDL (high-density-lipoprtein) < 1.03 mmol/L for males and < 1.29 mmol/L for females, 11ALT (alanine aminotransferase) > twice upper limit of
normal, 12as determined by ultrasonographic criteria excluding excess alcohol users and those with viral infection.
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the subject. Another was that we were unable to assess
inter-observer reliability between the sonographers before
the commencement of the study.
Male sex was a significant independent predictor of
NAFLD in our study. Though early studies in Western
populations found that NAFLD was more prevalent in
women, a more recent population-based study from the
USA has shown that men have a higher prevalence of
presumed NAFLD, based on elevated aminotransferases
[16]. Another recent study from Korea also showed a
higher prevalence of NAFLD among men compared to
women [17]. Undisclosed alcohol abuse, which has been
given as one possible explanation for the higher preva-
lence of NAFLD in men, may be relevant in this study
too. 18% of men reporting weekly alcohol consumption
above safe limit is one indication for this. However, it is
also known that women in the estate sector in Sri Lanka
are more physically active compared to the estate males;
65% of the plantation labour force is constituted of
female tea pluckers [18]. Abdominal obesity which is
considered to be an important risk factor for metabolic
syndrome and related diseases was also more prevalent
in estate males than females, though not significantly.
These are possible explanations for finding male sex as
an independent risk factor for NAFLD in the present
study.
There is increasing evidence for a genetic basis for the
development of NAFLD. Schwimmer et al. report famil-
ial factors as a major determinant of NAFLD [19].
Others have reported racial and ethnic differences in the
prevalence of the condition [20,21]. Petersen et al. have
shown that polymorphisms C-482T and T-455C in
APOC3 are associated with nonalcoholic fatty liver dis-
ease and insulin resistance in healthy Asian Indian men
[22]. Our finding of a high NAFLD prevalence in a
rural, physically active, predominantly Tamil estate
population from Sri Lanka supports results of studies
reporting ethnic variations in susceptibility.
Conclusion
In conclusion, we found that nearly one in five people in
a predominantly Indian Tamil, rural, physically active,
economically deprived population had NAFLD. The
condition was associated with constituent features of the
metabolic syndrome. Our findings also support results
of family studies and studies reporting ethnic variations
in susceptibility which suggest that genetic factors can
also play an important role in determining disease risk.
Table 2 Factors significantly associated with NAFLD among the estate population
Variable Number (%) with NAFLD Odds Ratio 95% Confidence Interval
Male sex 45 (23.8) 2.1 1.2-3.7
Higher education level1 29 (40.8) 4.6 2.5-8.9
Higher income2 26 (31.7) 2.8 1.5-5.0
Low activity levels3 25 (27.5) 2.1 1.2-3.8
BMI ≥ 25 kg/m2 30 (63.8) 13.1 6.3-27.3
High waist circumference4 36 (61.0) 13.3 6.8-26.2
High systolic blood pressure5 52 (22.4) 2.2 1.2-3.9
High diastolic blood pressure6 49 (26.3) 2.9 1.7-5.3
High plasma glucose7 30 (30.3) 2.7 1.5-4.8
Insulin resistance8 37 (43.5) 6.2 3.4-11.2
High triglycerides9 39 (28.1) 2.7 1.6-4.7
1educated upto Ordinary Level (grade 10) or above, 2income > Rs.10,000 (~US$ 100), 3as classified by International Physical Activity Questionnaire [IPAQ], 4waist
circumference > 90 cm for men, > 80 cm for female, 5 systolic blood pressure ≥ 180 mmHg, 6diastolic blood pressure ≥ 85 mmHg, 7fasting plasma glucose (FPG)
≥5.6 mmol/L or previously diagnosed type 2 diabetes, 8homeostasis model assessment of insulin resistance [HOMA-IR] > 1, 9triglycerides ≥1.7 mmol/L
Table 3 Summary of logistic regression analysis of factors associated with NAFLD
Variable b Standard error Odds ratio 95% Confidence interval P-value
Male sex 0.919 0.334 2.6 1.3-4.8 0.006
BMI ≥ 25 kg/m2 1.576 0.506 4.8 1.8-13.0 0.002
High waist circumferencea 1.664 0.444 5.3 2.2-12.6 < 0.001
High diastolic blood pressureb 0.779 0.320 2.2 1.2-4.1 0.015
High plasma glucosec 0.970 0.329 2.6 1.4-5.0 0.003
Constant -3.430 0.363
awaist circumference > 90 cm for men, > 80 cm for female, bdiastolic blood pressure ≥ 85 mmHg, cfasting plasma glucose (FPG) ≥ 5.6 mmol/L
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